Video by PCR via YouTube
Go to Source

In this roundtable discussion, Marianna Adamo, Philipp Lurz, and Sam Dawkins explore the one-year outcomes of the TRISCEND II Pivotal Trial, highlighting its potential to redefine the management of severe tricuspid regurgitation. They delve into the trial’s impact on patients’ quality of life, examine its limitations, and discuss the clinical significance of these groundbreaking results.

Supported by Edwards Lifesciences

More interviews on PCRonline: https://www.pcronline.com/Cases-resources-images/Resources/Educational-interviews

#heartfailure #tricuspidregurgitation #TTVR

Go to Source